TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Kirby Mcinerney Llp
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

Law firm investigating potential securities fraud at Anika Therapeutics after clinical trial results showed missed endpoints, causing stock price to drop 27.42% on July 30, 2025.

Insights
CADEpA   neutral

Proposed sale to Huntington Bancshares with stock conversion ratio of 2.475 shares


ANIK   negative

Stock price dropped significantly after clinical trial failed to meet pre-specified endpoints, with potential legal investigation suggesting potential misrepresentation of trial results